• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18595 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vildagliptin (Galvus®) 50 mg tablets
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Vildagliptin
2008     Belgian Health Care Knowledge Centre (KCE) Video registration of endoscopic surgery: a rapid assessment
2004     Medical Advisory Secretariat (MAS) Video laryngoscopy for tracheal intubation: an evidence-based analysis
2007     HAYES, Inc. Video electroencephalograph (VEEG) monitoring for diagnosis of epilepsy in children
2013     HAYES, Inc. Video Electroencephalogram (VEEG) for diagnosis and management of epilepsy in adults
2013     HAYES, Inc. Video Electrencephalogram (VEEG) for the diagnosis and treatment of epilepsy in children
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Video capsule endoscopy for obscure GI bleeding and Crohn's disease (Update of Report 7)
2022     NIHR Health Technology Assessment programme VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a multi-centre randomised controlled trial with an internal pilot. The VIOLET Study
2000     The Swedish Council on Health Technology Assessment (SBU) Viagra for impotence - early assessment briefs (ALERT)
2008     HAYES, Inc. Vestibulectomy for treatment of vulvar vestibulitis
2003     ECRI Vestibular rehabilitation and particle repositioning for benign positional vertigo
1991     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Vesicular Lithiasis: therapeutic strategy for gallbladder - consensus conference
2011     NIHR Horizon Scanning Centre (NIHR HSC) VERV patient managed transdermal neuromodulation system for overactive bladder syndrome
2010     Center for Evidence-based Practice (CEP) Vertos mild for lumbar decompression
2006     HAYES, Inc. Vertical expandable prosthetic titanium rib (VEPTR) (Synthes Inc.) for thoracic insufficiency syndrome
2006     HAYES, Inc. Vertical expandable prosthetic titanium rib (VEPTR) (Synthes Inc.) for percutaneous neuromodulation therapy for low back pain
2012     NIHR Health Technology Assessment programme Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK
2021     Swiss Federal Office of Public Health (FOPH) Vertebroplasty or kyphoplasty in painful osteoporotic vertebral compression fractures unresponsive to non-surgical treatment
2005     Adelaide Health Technology Assessment (AHTA) Vertebroplasty and kyphoplasty for the treatment of vertebral compression fracture
2004     Institute for Clinical Systems Improvement (ICSI) Vertebroplasty and balloon-assisted vertebroplasty for the treatment of osteoporotic compression fractures
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Vertebroplasty
2001     Medical Services Advisory Committee (MSAC) Vertebral axial decompression therapy for chronic low back pain
2005     WorkSafe BC Vertebral axial decompression for low back pain
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: OHTAC recommendation
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: an economic analysis
2016     Health Quality Ontario (HQO) Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: a systematic review
2006     Adelaide Health Technology Assessment (AHTA) Vertebral assessment with DEXA: Screening for vertebral fracture during risk assessment for osteoporosis
2007     Adelaide Health Technology Assessment (AHTA) Vertebral assessment with DEXA
2004     Blue Cross Blue Shield Association (BCBS) Vertebral assessment using dual-energy x-ray absorptiometry for osteoporotic fracture risk assessment
2019     NIHR Health Technology Assessment programme Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT
2013     HAYES, Inc. VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2012     HAYES, Inc. VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2011     HAYES, Inc. VersaJet hydrosurgery system (Smith&Nephew Inc.) for treatment of burns
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vernakalant (IV) (Brinavess) for the treatment of recent onset atrial fibrillation
2012     HAYES, Inc. VeriStrat® Test to predict response to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC)
2014     HAYES, Inc. VeriStrat test to predict response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC)
2016     HAYES, Inc. VeriStrat
2010     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Veress needle laparoscopic entry technique
2016     HAYES, Inc. Verasense (OrthoSensor Inc.) for use during total knee arthroplasty
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vepoloxamer for vaso-occlusive crises in sickle cell disease – first line
2014     NIHR Health Technology Assessment programme VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model
2011     NIHR Health Technology Assessment programme VenUS III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers
2009     NIHR Health Technology Assessment programme VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers
2004     NIHR Health Technology Assessment programme VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers
2003     HAYES, Inc. Ventricular reduction surgery
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Ventricular assistance devices as mechanical bridge to cardiac transplantation (internal report) IPE-97/f
2010     HAYES, Inc. Ventricular Assist Devices (VADs) in children and adolescents with chronic, end-stage heart failure
2005     HAYES, Inc. Ventricular assist devices
2003     HAYES, Inc. Ventricular assist devices
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Ventilation/perfusion scintigraphy (using Technegas) versus computed tomography pulmonary angiography for the diagnosis of pulmonary embolism in hospitalized patients: a review of the clinical and cost-effectiveness
2013     New Zealand National Health Committee (NHC) Ventilation tubes: an opportunity for better targeting - technology note
2001     Norwegian Knowledge Centre for the Health Services (NOKC) Ventilation in operating theatres
2007     National Institute for Health and Clinical Excellence (NICE) Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery
2012     Agency for Healthcare Research and Quality (AHRQ) Venous thromboembolism prophylaxis in orthopedic surgery
2007     Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for medical inpatients
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Venous thromboembolism prophylaxis for major general surgery: a review of the clinical effectiveness and guidelines
2007     Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for ischemic stroke
2007     Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for hip fracture patients
2009     Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for bariatric surgery
2018     Center for Evidence-based Practice (CEP) Venous Thromboembolism Prevention for Obese Patients
2021     NIHR Health Technology Assessment programme Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT
2016     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax with rituximab for relapsed or refractory chronic lymphocytic leukaemia – second and subsequent line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax for chronic lymphocytic leukaemia with 17p deletion or TP53 mutation
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Venetoclax (Venclexta™) for the treatment of relapsed or refractory chronic lymphocytic leukaemia (CLL) with chromosome 17p deletion
2012     NIHR Health Technology Assessment programme Vemurafenib for the treatment of locally advanced or metastatic BRAF V600E mutation positive malignant melanoma
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vemurafenib for the 1st –line unresectable stage IIIC or IV melanoma
2014     NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib and cobimetinib for previously untreated BRAFV600-mutation positive, unresectable, locally advanced or metastatic melanoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vemurafenib (Zelboraf) for metastatic BRAF V600 mutation positive melanoma in children and adolescents
2008     Adelaide Health Technology Assessment (AHTA) Velscope(R) for oral cancer screening
2010     Adelaide Health Technology Assessment (AHTA) Velscope for oral cancer screening
2016     NIHR Horizon Scanning Centre (NIHR HSC) Veliparib with carboplatin and paclitaxel for early-stage triple negative breast cancer ─ neoadjuvant therapy
2012     NIHR Horizon Scanning Centre (NIHR HSC) Velimogene aliplasmid (Allovectin) for advanced or metastatic malignant melanoma
2014     NIHR Horizon Scanning Centre (NIHR HSC) Velcalcetide for secondary hyperparathyroidism – first line
2010     HAYES, Inc. Velcade (Bortezomib) (Millennium: The Takeda Oncology Company) for mantle cell lymphoma
2009     NIHR Horizon Scanning Centre (NIHR HSC) Velaglucerase alfa for type 1 Gaucher's disease
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Velaglucerase alfa
2012     HAYES, Inc. VeinViewer (Christie Digital Systems USA Inc.) for guiding venous access procedures in children
1998     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Vein-graft surveillance - primary research
2011     NIHR Horizon Scanning Centre (NIHR HSC) VEGF trap-eye (Eylea) for macular oedema secondary to central retinal vein occlusion - first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Vedolizumab for ulcerative colitis – second or subsequent line
2014     NIHR Health Technology Assessment programme Vedolizumab for treating moderate to severe active Crohn's disease after prior therapy [ID690]
2013     NIHR Horizon Scanning Centre (NIHR HSC) Vedolizumab for Crohn's disease – second or subsequent line
2012     NIHR Horizon Scanning Centre (NIHR HSC) VBLOC® vagal blocking therapy for obesity
2009     HAYES, Inc. VasoView HemoPro endoscopic vein harvesting system (Maquet Cardiovascular LLC) for coronary artery bypass graft (CABG)
2005     Adelaide Health Technology Assessment (AHTA) Vasotrac (R) continuous blood pressure monitoring
2003     Centre for Clinical Effectiveness (CCE) Vasospasm following subarachnoid haemorrhage: papaverine infusion, nimodipine infusion or balloon angioplasty?
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vasoprotectives: efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoids
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Vasopressin as first-line therapy for cardiac arrest: a review of the guidelines and clinical-effectiveness
2015     Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review (update)
2013     Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vascular-targeted photodynamic therapy with padeliporfin (Tookad® Soluble)
1989     The Swedish Council on Health Technology Assessment (SBU) Vascular surgery for arteriosclerosis in the legs
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Vascular endothelial growth factor inhibitors (pegaptanib, ranibizumab and bevacizumab) in age-related macular degeneration treatment
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Vascular endothelial growth factor inhibitors (pegaptanib, ranibizumab and bevacizumab) in age-related macular degeneration treatment
2004     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Vascular bipolar electrocoagulation (LigaSure (TM)) and Tissular electrocoagulation and section (TissueLink (TM)) - preliminary report
2000     University HealthSystem Consortium (UHC) Varicella-zoster
2014     New Zealand National Health Committee (NHC) Varicella and rotovirus vaccination in New Zealand - assessment reports
2020     NIHR Health Services and Delivery Research programme Variations in the organisation of Early Pregnancy Assessment Units (EPAUs) in the UK and their effects on clinical, service and patient-centred outcomes (VESPA)
1993     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Variations in the frequency of surgical procedures by region in the province of Quebec - nonsystematic review